Thunen Shelley B's Form 4 filing
RxSight, Inc.RXST · filed Oct 2, 2024
- Accession no.
- 0000950170-24-111461
- Filed
- Oct 2, 2024
- Trade date
- Oct 1, 2024
- Filing delay
- 1 day
- Rule 10b5-1 plan
- Checked
This filing lists 4 non-derivative transactions and 1 derivative transaction. Open-market sales total $726.8K. It was filed 1 day after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Thunen Shelley BCIK 0001297491 | Officer (See remarks) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Oct 1, 2024 | Common Stock | MOption exerciseAcquired | +15,000 | $16.00 | +$240,000 | 45,443 | Direct | |
| Oct 1, 2024 | Common Stock | SSaleDisposed | −5,201 | $47.96F2 | −$249,439.96 | 40,242 | Direct | |
| Oct 1, 2024 | Common Stock | SSaleDisposed | −9,521 | $48.69F3 | −$463,577.49 | 30,721 | Direct | |
| Oct 1, 2024 | Common Stock | SSaleDisposed | −278 | $49.45 | −$13,747.1 | 30,443 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Oct 1, 2024 | Common Stock | MOption exerciseDisposed | −15,000 | $0.00 | $0 | 83,367 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F2
Represents the weighted average share price of an aggregate total of 5,201 shares sold in the price range of $47.36 to $48.29 by the Reporting Person. The Reporting Person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
Referenced by the price of 1 transaction in Table I.
- F3
Represents the weighted average share price of an aggregate total of 9,521 shares sold in the price range of $48.375 to $49.08 by the Reporting Person. The Reporting Person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
Referenced by the price of 1 transaction in Table I.
Remarks
Co-President and Chief Financial Officer